An Interest In:
Web News this Week
- March 28, 2024
- March 27, 2024
- March 26, 2024
- March 25, 2024
- March 24, 2024
- March 23, 2024
- March 22, 2024
October 6, 2017 05:23 pm GMT
Original Link: http://feedproxy.google.com/~r/Techcrunch/~3/9sGKy0O0WRI/
Roivant looks to quickly turn the page, starting with a Phase 3 win
A new hormonal therapy designed to treat uterine fibroids called relugolix has finished a Phase 3 study in Japan, and the results are positive. That’s welcome news for a SoftBank-backed company based in Basel, Switzerland calledRoivant Sciences that’s separately dealing with much lousier news. Read MoreOriginal Link: http://feedproxy.google.com/~r/Techcrunch/~3/9sGKy0O0WRI/
Share this article:
Tweet
View Full Article
Techcrunch
TechCrunch is a leading technology blog, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news.More About this Source Visit Techcrunch